Novel Calmodulin Mutations Associated With Congenital Arrhythmia Susceptibility
Proband
Sudden Death
DOI:
10.1161/circgenetics.113.000459
Publication Date:
2014-06-11T02:15:54Z
AUTHORS (39)
ABSTRACT
Background— Genetic predisposition to life-threatening cardiac arrhythmias such as congenital long-QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT) represent treatable causes of sudden death in young adults children. Recently, mutations calmodulin ( CALM1 , CALM2 ) have been associated with severe forms LQTS CPVT, occurring very early life. Additional mutation-positive cases are needed discern genotype–phenotype correlations mutations. Methods Results— We used conventional next-generation sequencing approaches, including exome analysis, genotype-negative probands. identified 5 novel de novo missense 3 subjects (p.N98S, p.N98I, p.D134H) 2 clinical features both CPVT (p.D132E, p.Q136P). Age onset major symptoms (syncope or arrest) ranged from 1 9 years. Three probands had arrest these did not survive. The severity among this series was generally less than that originally reported for recurrent during infancy. Four responded β-blocker therapy, whereas subject mutation p.Q136P died suddenly exertion despite treatment. Mutations affect conserved residues located within Ca 2+ -binding loops III p.N98I) IV p.D134H, p.Q136P) caused reduced affinity. Conclusions— can be overlapping CPVT.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (43)
CITATIONS (166)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....